1-(4-Sulphoxybenzol)-3,3-dimethyltriazen | 35433-91-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1-(4-Sulphoxybenzol)-3,3-dimethyltriazen
• 英文别名: p-Dimethylaminoazobenzenesulfonic acid；4-(dimethylaminodiazenyl)benzenesulfonic acid
• CAS: 35433-91-1
• 化学式: C₈H₁₁N₃O₃S
• 分子量: 229.26
• InChiKey: QEVNEOGSQSBJIZ-UHFFFAOYSA-N

物化性质

• 密度：
  1.35±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  90.7
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  对氨基苯磺酸 在 二氧化氮 作用下， 生成 1-(4-Sulphoxybenzol)-3,3-dimethyltriazen
  参考文献：
  名称：

  Kaupp, Gerd; Schmeyers, Jens; Haak, Michael, Molecular Crystals and Liquid Crystals Science and Technology, Section A: Molecular Crystals and Liquid Crystals, 1996, vol. 276-277, p. 315 - 317

  摘要：

  DOI：

文献信息

• [EN] BIOREVERSABLE PROMOIETIES FOR NITROGEN-CONTAINING AND HYDROXYL-CONTAINING DRUGS<br/>[FR] PRO-FRAGMENTS BIORÉVERSIBLES POUR MÉDICAMENTS CONTENANT DE L'AZOTE ET DE L'HYDROXYLE
  申请人：BAIKANG SUZHOU CO LTD

  公开号：WO2015081891A1

  公开（公告）日：2015-06-11

  Disclosed are promoieties of the following formula which can be used to form prodrugs of nitrogen-containing or hydroxyl-containing drug or a pharmaceutically active agent: (I) and pharmaceutical compositions comprising the prodrugs.

  披露了以下公式的促销性质，它们可用于形成含有氮或羟基的药物或药物活性剂的的前药：(I)以及包含这些前药的药物组合物。
• Dielectric fluids having reduced streamer speed
  申请人：ABB Research Ltd.

  公开号：US10109388B2

  公开（公告）日：2018-10-23

  The present invention relates to a liquid composition for electrical insulation including a dielectric fluid and an additive, the additive being dissolved in the dielectric fluid and having a 1st excitation energy which is lower than the 1st excitation energy of the dielectric fluid.

  本发明涉及一种用于电气绝缘的液体组合物，包括介电流体和添加剂，添加剂溶解在介电流体中，其第一激发能低于介电流体的第一激发能。
• Bioreversable promoieties for nitrogen-containing and hydroxyl-containing drugs
  申请人：Han Jie

  公开号：US10626156B2

  公开（公告）日：2020-04-21

  Disclosed are promoieties of the following formula which can be used to form prodrugs of nitrogen-containing or hydroxyl-containing drug or a pharmaceutically active agent: and pharmaceutical compositions comprising the prodrugs.

  本发明公开了下式的原药，可用于形成含氮或含羟基药物或药物活性剂的原药： 以及含有这些原药的药物组合物。
• Abfallfreie Gas/Festkörper-Diazotierung mit Stickstoffdioxid und quantitative Triazensynthese ohne Flüssigphase
  作者：Gerd Kaupp、Andreas Herrmann

  DOI：10.1002/prac.19973390145

  日期：——

  Solid diazonium nitrates (2a-j) are quantitatively obtained by reaction of crystalline anilines (1a-j) with gaseous nitrogen dioxide. Solid diazonium salts react quantitatively with dimethylamine to give the triazenes (4a-j). Wastes that are typical for the previous syntheses of these compounds in solution are avoided. Atomic force microscopic (AFM) investigations indicate long-range molecular movements due to phase rebuilding. The features thus formed are related to the known crystal structures of the starting anilines. The diazotations run to completion, because, after accumulation of product molecules, phase transformation to give the product lattices leads to crystal disintegration and thus to formation of fresh surface over and over.
• ANTI-BIOCONTAMINANT PRODUCTS AND PROCESSES FOR MAKING THE SAME
  申请人：Dynamic Adsorbents, Inc

  公开号：EP1988848A2

  公开（公告）日：2008-11-12